DRUG STUDY

NAME OF PATIENT:

GENERIC/ CLASSIFICA DOSAGE/TIMING INDICATION MECHANISM ADVERSE NURSING

BRAND TION /ROUTE OF ACTION EFFECT RESPONSIBILITIES
NAME
Generic Ketoanalogs; • Four to eight Indications Normalizes • Hyperca • Evaluate for any
Name: Essential tabs TID metabolic lcemia contraindications
Essential amino acids • 1 tab/5kg • Protein process, may • Take drug as prescribed
Amino Acids body energy promotes develop • Warn the patient about
weight/day malnutri recycling possible side effects and
Brand tion product how to recognize them
Name: • Preventi exchange. • Give with food if GI upset
Ketosteril on and Reduces ion occurs
treatmen concentration of • Frequently assess for
t of potassium, hypercalcemia
conditio magnesium and
ns phosphate.
caused
by
modifie
d or
insuffici
ent
protein
metaboli
sm in
chronic
renal
failure

Contraindicati
ons:

• Allergy
and
 hyperse
nsitivity
to any
content
of this
drug
• Hyperca
lcemia
• Disturbe
d amino
acid
metaboli
sm
• Caution
use for
patietn
with
phenylk
etonuria
 DRUG STUDY

NAME OF PATIENT: Sultan, Rakimah DATE OF ADMISSION: January 11, 2010

GENERIC/ CLASSIFICA DOSAGE/TIMING INDICATION MECHANISM ADVERSE NURSING

BRAND TION /ROUTE OF ACTION EFFECT RESPONSIBILITIES
NAME
Mefenamic NSAID 500 mg; cap q 8 Relief of pain Aspirin – like GI • Assess patient’s pain
Acid hours including drug that discomfort, before therapy
muscular, has diarrhea or • Monitor for possible
rheumatic, analgesic, constipation, drug induced adverse
traumatic, antipyretic, gas pain, reactions
dental, post and anti- nausea, • Advice patient not to
op and post inflammator vomiting, take drug for more
partum pain, y activities drowsiness than 7 days
headache, • Advice patient to
migraine, report immediately
fever, persistence or failure
dysmenorrh to relieve pain
ea

CONTRAINDI
CATION

Pregnancy
and
lactation,
hypersensiti
vity, active
ulceration or
chronic
inflammation
of either
lower or
upper GIT,
blood
disorders,
poor platelet
function,
kidney or
liver
impairment
 DRUG STUDY

NAME OF PATIENT: Sultan, Rakimah DATE OF ADMISSION: January 11, 2010

GENERIC/ CLASSIFICA DOSAGE/TIMING INDICATION MECHANISM ADVERSE NURSING

BRAND TION /ROUTE OF ACTION EFFECT RESPONSIBILITIES
NAME
Ampicillin Anti- Amp IVTT (-) Skin and skin Bactericidal CNS: Assessment:
infectives ANST q 6 hours structure action; seizures • Assess patient for
infections, spectrum is GI: infection
soft tissue broader than pseudomem • Obtain history before
infections, penicillin branous initiating therapy to
otitis media, colitis, determine previous
sinusitis, diarrhea, use and reactions to
respiratory nausea, penicillin and
infections, vomiting cephalosporins
GU Derm: • Observe patient for
infections, rashes, signs and symptoms
meningitis, urticaria of anaphylaxis
septicaemia Hemat: • Assess skin for
blood “ampicillin rash”
CONTRAINDI dyscrasias
CATION Implementation:
• Do not confuse with
Hypersensitiv omnipen with
ity to imipenem
penicillins • Reserve IM or IV
route for moderately
severe or severe
infections or patients
unable to take oral
medication. Change
to PO as soon as
possible
 DRUG STUDY

NAME OF PATIENT: Sultan, Rakimah DATE OF ADMISSION: January 11, 2010

GENERIC/ CLASSIFICA DOSAGE/TIMING INDICATION MECHANISM ADVERSE NURSING

BRAND TION /ROUTE OF ACTION EFFECT RESPONSIBILITIES
NAME
Metronidaz Anti- 500 mg; IVTT (-) Treatment Bactericidal, CNS: Assessment:
ole infectives, ANST q 8 hours for trichomonaci seizure, • Assess patient for
antiprotozo anaerobic dal, dizziness, infection
al, antiulcer infection like amebicidal headache • Obtain specimens for
gynecologic action GI: culture and sensitivity
infection. abdominal before initiating
pain, therapy
CONTRAINDI anorexia, • Monitor neurologic
CATION nausea, status during and
diarrhea, dry after infusions
Hypersensiti mouth, furry • Monitor I&O and daily
vity to tongue, weight
parabens. glossitis,
First unpleasant Implementation:
trimester of taste, • Preparation of Flagyl
pregnancy vomiting IV, powder for
Derm: reconstitution
rashes, requires a specific
urticaria,bur process. Do not use
ning, mild aluminium needles or
dryness, hubs, color will turn
skin orange/rust
irritation,
transient
redness
Hemat:
leukopenia
 DRUG STUDY

NAME OF PATIENT: Sultan, Rakimah DATE OF ADMISSION: January 11, 2010

GENERIC/ CLASSIFICA DOSAGE/TIMING INDICATION MECHANISM ADVERSE NURSING

BRAND TION /ROUTE OF ACTION EFFECT RESPONSIBILITIES
NAME
Amikacin Antibiotic 50 mg IVTT q 12 Treatment of Bactericidal EENT: ASSESSMENT:
hours ANST serious gram- action ototoxicity • Assess for infection
negative GU: • Evaluate eighth
bacillary nephrotoxi cranial nerve function
infections and city by audiometry before
infections MS: muscle and throughout
caused by paralysis therapy
staphylococci • Monitor I&O
when
penicillins or IMPLEMENTATION:
other less • Keep patient well
toxic drus are dehydrated
contraindicate • Do not confuse
d amikacin to amicar

CONTRAINDIC
ATION

Hypersensitivi
ty
 NURSING CARE PLAN

NAME OF PATIENT: Sultan, Rakimah DATE: JANUARY 11, 2010

ASSESSMENT DIAGNOSIS OBJECTIVE INTERVENTION RATIONALE EVALUATION

Nsg Hx: Self care At the end • Help the patient to  So that the patient’s At the end of
Pt RS, Deficit of 30 comb her hair hair will be combed 30 minutes,
a 24 year old related to minutes, properly the goal is
female was untidy patient will • Encourage patient to  For the patient to look met, the
admitted due appearance be nice and wear a clean dress clean patient is
to incomplete clean to now nice and
abortion look at • Help patient to wear  To be properly dress clean to look
the dress if unable to and will not expose any at
Subj Cue: do so private part of the
patient
• Make use of make – up  To add up beauty to the
patient

Obj Cue:

Untidy dress
Uncombed
hair

Lab:
 DRUG STUDY

NAME OF PATIENT: Silgas, Cyrus DATE OF ADMISSION: January 19, 2010

GENERIC/ CLASSIFICA DOSAGE/TIMING INDICATION MECHANISM ADVERSE NURSING

BRAND TION /ROUTE OF ACTION EFFECT RESPONSIBILITIES
NAME
Zinc Supplement Drops mL PO; Replacement Replacement GI: gastric Assessment:
Sulfate OD and in deficiency irritation, • Monitor progression
supplementa states nausea, of zinc deficiency
tion therapy vomiting symptoms during
in patients therapy
who are risk • Monitor HDL
for zinc concentrations
deficiency, monthly in patients
including long-term high-dose
patients on zinc therapy
long-term
parenteral Implementation:
nutrition • Administer oral doses
with food to decrease
CONTRAINDI gastric irritation.
CATION

Hypersensiti
vity or
allergy to
any
components
in
formulation